Published in J Neurosurg on February 01, 1999
The endoscopic endonasal approach for the management of craniopharyngiomas involving the third ventricle. Neurosurg Rev (2012) 2.06
"Conservative" surgical approach and early postoperative radiotherapy in a patient with a huge cystic craniopharyngioma. Childs Nerv Syst (2005) 1.51
Extended endoscopic endonasal approach to the suprasellar parachiasmatic cisterns: anatomic study. Childs Nerv Syst (2010) 1.41
Patterns of care for craniopharyngioma: survey of members of the american association of neurological surgeons. Pediatr Neurosurg (2014) 1.41
Treatment options for pediatric craniopharyngioma. Surg Neurol Int (2016) 1.38
Childhood craniopharyngioma--current concepts in diagnosis, therapy and follow-up. Nat Rev Endocrinol (2010) 1.08
Pituitary tumors in childhood: update of diagnosis, treatment and molecular genetics. Expert Rev Neurother (2008) 1.06
The role of fractionated radiotherapy and radiosurgery in the management of patients with craniopharyngioma. Neurosurg Rev (2009) 1.03
Craniopharyngioma. Orphanet J Rare Dis (2007) 0.98
Treatment strategies in childhood craniopharyngioma. Front Endocrinol (Lausanne) (2012) 0.97
Extracranial infrasellar ectopic craniopharyngioma: a case report and review of the literature. Skull Base (2010) 0.97
Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma. J Neurooncol (2010) 0.97
Craniopharyngioma in adults. Front Endocrinol (Lausanne) (2012) 0.93
The role of the endoscope in the transsphenoidal management of cystic lesions of the sellar region. Neurosurg Rev (2007) 0.93
Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN. Neuro Oncol (2017) 0.93
Treatment outcomes of pediatric craniopharyngioma : a 15-year retrospective review of 35 cases. J Korean Neurosurg Soc (2012) 0.93
A systematic review of the results of surgery and radiotherapy on tumor control for pediatric craniopharyngioma. Childs Nerv Syst (2012) 0.92
Clinical features of nonpituitary sellar lesions in a large surgical series. Clin Endocrinol (Oxf) (2010) 0.88
Diagnostics, treatment, and follow-up in craniopharyngioma. Front Endocrinol (Lausanne) (2011) 0.87
Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity. Int J Radiat Oncol Biol Phys (2014) 0.87
Combined endoscopic and microscopic management of pediatric pituitary region tumors through one nostril: technical note with case illustrations. Childs Nerv Syst (2008) 0.86
Origin of craniopharyngiomas: implication on the growth pattern. Childs Nerv Syst (2005) 0.85
Neurosurgical treatment strategies in childhood craniopharyngiomas: is less more? Childs Nerv Syst (2009) 0.85
Predictive factors for vision recovery after optic nerve decompression for chronic compressive neuropathy: systematic review and meta-analysis. J Neurol Surg B Skull Base (2012) 0.84
PET imaging in the surgical management of pediatric brain tumors. Childs Nerv Syst (2007) 0.84
Craniopharyngiomas in children: how radical should the surgeon be? Childs Nerv Syst (2010) 0.84
Pediatric suprasellar lesions. J Pediatr Neurosci (2011) 0.84
Different approaches in radiation therapy of craniopharyngioma. Front Endocrinol (Lausanne) (2011) 0.84
Recurrence in pediatric craniopharyngiomas: analysis of clinical and histological features. Childs Nerv Syst (2005) 0.83
Endoscopic endonasal transsphenoidal approach to sellar lesions: a detailed account of our mononostril technique. J Neurol Surg B Skull Base (2013) 0.82
A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas. Virchows Arch (2010) 0.81
Minimally invasive management of adult craniopharyngiomas: An analysis of our series and review of literature. Surg Neurol Int (2013) 0.80
Pituitary stalk craniopharyngioma. BMJ Case Rep (2011) 0.80
[Hypopituitarism]. Internist (Berl) (2004) 0.80
Anterior callosal section is useful for the removal of large tumors invading the dorsal part of the anterior third ventricle: operative technique and results. Neurosurg Rev (2013) 0.79
Craniopharyngioma in children: Marseille experience. Childs Nerv Syst (2005) 0.79
Craniopharyngiomas in children: Turkey experience. Childs Nerv Syst (2005) 0.79
Management of craniopharyngioma: the Liverpool experience following the introduction of the CCLG guidelines. Introducing a new risk assessment grading system. Childs Nerv Syst (2012) 0.79
Correlation between clinical characteristics and proliferative activity in patients with craniopharyngioma. J Neurol Neurosurg Psychiatry (2004) 0.78
Purely neuroendoscopic transventricular management of cystic craniopharyngiomas. Childs Nerv Syst (2004) 0.78
Positron emission tomography for the early postsurgical evaluation of pediatric brain tumors. Childs Nerv Syst (2004) 0.78
Extended endoscopic endonasal transsphenoidal approach for retrochiasmatic craniopharyngioma: Surgical technique and results. J Pediatr Neurosci (2016) 0.78
Intracavitary therapeutic options in the management of cystic craniopharyngioma. Childs Nerv Syst (2005) 0.77
Non-adenomatous sellar lesions: experience of a single centre and review of the literature. Neurosurg Rev (2010) 0.77
Neuroendocrine Disorders in Pediatric Craniopharyngioma Patients. J Clin Med (2015) 0.77
Pituitary stalk management during the microsurgery of craniopharyngiomas. Exp Ther Med (2014) 0.77
Controlled release of imatinib mesylate from PLGA microspheres inhibit craniopharyngioma mediated angiogenesis. J Mater Sci Mater Med (2012) 0.77
Giant craniopharyngiomas in children: short- and long-term implications. Childs Nerv Syst (2015) 0.77
Early outcome in endoscopic extended endonasal approach for removal of supradiaphragmatic craniopharyngiomas: a case series and a comprehensive review. Radiol Oncol (2013) 0.76
Optimal treatment strategy for craniopharyngiomas based on long-term functional outcomes of recent and past treatment modalities. Neurosurg Rev (2010) 0.76
Is the Complete Resection of Craniopharyngiomas in Adults Feasible Considering Both the Oncologic and Functional Outcomes? J Korean Neurosurg Soc (2015) 0.76
Preliminary Study on Composition and Microstructure of Calcification in Craniopharyngiomas. J Craniofac Surg (2016) 0.75
Interleukin‑6 induces an epithelial‑mesenchymal transition phenotype in human adamantinomatous craniopharyngioma cells and promotes tumor cell migration. Mol Med Rep (2017) 0.75
Visual Outcomes after Endoscopic Endonasal Approach for Craniopharyngioma: The Pittsburgh Experience. J Neurol Surg B Skull Base (2016) 0.75
Recurrent ectopic craniopharyngioma in the sylvian fissure thirty years after resection through a pterional approach: a case report and review of the literature. Nagoya J Med Sci (2015) 0.75
A flexible endoscope-assisted interhemispheric transcallosal approach through the contralateral ventricle for the removal of a third ventricle craniopharyngioma: A technical report. Surg Neurol Int (2015) 0.75
Anorexia-cachexia syndrome-like hypothalamic neuroendocrine dysfunction in a patient with a papillary craniopharyngioma. Endocrinol Diabetes Metab Case Rep (2017) 0.75
Fronto-basal interhemispheric approach for craniopharyngiomas extending outside the suprasellar cistern. Childs Nerv Syst (2005) 0.75
Radical resection of a craniopharyngioma via the extradural anterior temporal approach with zygomatic arch osteotomy. Surg Neurol Int (2016) 0.75
Influence of previous treatments on repeat surgery for recurrent craniopharyngiomas in children. Childs Nerv Syst (2016) 0.75
A reformed surgical treatment modality for children with giant cystic craniopharyngioma. Childs Nerv Syst (2017) 0.75
Outcome following surgical resection of craniopharyngiomas: A case series. Asian J Neurosurg (2017) 0.75
Treatment of Cystic Craniopharyngioma with Intracystic Stereotactic Instillation of Phosphorus 32. Iran J Child Neurol (2017) 0.75
Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol (2000) 12.01
Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans. Neurology (2001) 7.03
Pharmacological modulation of cortical excitability shifts induced by transcranial direct current stimulation in humans. J Physiol (2003) 4.08
Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol (1996) 4.02
Shaping the effects of transcranial direct current stimulation of the human motor cortex. J Neurophysiol (2007) 3.15
Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J Control Release (2000) 3.07
Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classification. Childs Nerv Syst (2001) 2.94
The effect of lorazepam on the motor cortical excitability in man. Exp Brain Res (1996) 2.92
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2008) 2.70
A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology (1984) 2.70
Infinite-layer iron oxide with a square-planar coordination. Nature (2007) 2.41
Partially non-linear stimulation intensity-dependent effects of direct current stimulation on motor cortex excitability in humans. J Physiol (2013) 2.39
Lymphocytic and granulomatous hypophysitis: experience with nine cases. Neurosurgery (1997) 2.37
Detection and prevention of the trigeminocardiac reflex during skull base surgery. Acta Neurochir (Wien) (2007) 2.28
Magnetic resonance spectroscopic imaging for visualization of the infiltration zone of glioma. Cent Eur Neurosurg (2010) 2.24
Posterior fossa neurovascular anomalies in essential hypertension. Lancet (1994) 2.22
Magnetic stimulation: motor evoked potentials. The International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl (1999) 2.10
Hydantoin syndrome with holoprosencephaly: a possible rare teratogenic effect. Teratology (1993) 2.04
Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group. J Clin Endocrinol Metab (1995) 2.00
Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations. Neurology (2007) 1.90
Demonstration of facilitatory I wave interaction in the human motor cortex by paired transcranial magnetic stimulation. J Physiol (1998) 1.89
Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study. Eur J Endocrinol (2007) 1.83
Rosetted glioneuronal tumor: a case with proliferating neuronal nodules. Acta Neuropathol (2001) 1.82
Effects of transcranial direct current stimulation over the human motor cortex on corticospinal and transcallosal excitability. Exp Brain Res (2004) 1.75
Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol (1996) 1.73
Neurologic manifestations of cerebral air embolism as a complication of central venous catheterization. Crit Care Med (2000) 1.70
Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem (1991) 1.70
Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis. Evidence from paired transcranial magnetic stimulation. Neurology (1997) 1.67
External modulation of visual perception in humans. Neuroreport (2001) 1.63
Difficult intubation in acromegalic patients: incidence and predictability. Anesthesiology (2000) 1.61
DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours. Eur J Endocrinol (2011) 1.48
Magnetic brain source imaging of focal epileptic activity: a synopsis of 455 cases. Brain (2003) 1.45
Pleomorphic xanthoastrocytoma: report of six cases with special consideration of diagnostic and therapeutic pitfalls. Surg Neurol (1997) 1.44
Applications of magnetic cortical stimulation. The International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl (1999) 1.44
Regional modulation of BOLD MRI responses to human sensorimotor activation by transcranial direct current stimulation. Magn Reson Med (2001) 1.42
Decreased motor inhibition in Tourette's disorder: evidence from transcranial magnetic stimulation. Am J Psychiatry (1997) 1.41
Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases. Am J Pathol (2001) 1.41
Elevated inferior petrosal sinus levels of PTHrP in a patient with Cushing's disease. Clin Endocrinol (Oxf) (2001) 1.40
[Diabetes screening in pregnant patients with different risk factors. Benefits, therapeutic success, consequences]. Z Geburtshilfe Neonatol (1996) 1.39
Time course of the induction of homeostatic plasticity generated by repeated transcranial direct current stimulation of the human motor cortex. J Neurophysiol (2010) 1.39
Hashimoto encephalopathy: a brainstem vasculitis? Neurology (2000) 1.31
Trigemino-cardiac reflex in humans initiated by peripheral stimulation during neurosurgical skull-base operations. Its first description. Acta Neurochir (Wien) (2008) 1.29
CD24 promotes invasion of glioma cells in vivo. J Neuropathol Exp Neurol (1999) 1.27
Brain iron and ferritin in Parkinson's and Alzheimer's diseases. J Neural Transm Park Dis Dement Sect (1990) 1.27
Intraoperative magnetic resonance imaging with the magnetom open scanner: concepts, neurosurgical indications, and procedures: a preliminary report. Neurosurgery (1998) 1.20
Theta burst stimulation induces after-effects on contralateral primary motor cortex excitability in humans. J Physiol (2008) 1.20
Lasting influence of repetitive transcranial magnetic stimulation on intracortical excitability in human subjects. Neurosci Lett (2000) 1.19
Tumors of the choroid plexus. Microsc Res Tech (2001) 1.19
Pharmacological control of facilitatory I-wave interaction in the human motor cortex. A paired transcranial magnetic stimulation study. Electroencephalogr Clin Neurophysiol (1998) 1.18
Diminution of training-induced transient motor cortex plasticity by weak transcranial direct current stimulation in the human. Neurosci Lett (2000) 1.17
Functional MRI of cortical activations induced by transcranial magnetic stimulation (TMS). Neuroreport (2001) 1.17
Molecular imaging of brain tumors: a bridge between clinical and molecular medicine? Mol Imaging Biol (2007) 1.17
Inhibition of human motor cortex by ethanol. A transcranial magnetic stimulation study. Brain (1995) 1.16
Complete suppression of voluntary motor drive during the silent period after transcranial magnetic stimulation. Exp Brain Res (1999) 1.15
BRAF-KIAA1549 fusion transcripts are less frequent in pilocytic astrocytomas diagnosed in adults. Neuropathol Appl Neurobiol (2011) 1.15
[Ophthalmic agents during pregnancy and breastfeeding]. Ophthalmologe (2012) 1.12
Intraoperative magnetic resonance imaging during transsphenoidal surgery. J Neurosurg (2001) 1.10
Stem cell protein BMI-1 is an independent marker for poor prognosis in oligodendroglial tumours. Neuropathol Appl Neurobiol (2008) 1.10
Human post-mortem striatal alpha4beta2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome. Neurosci Lett (2000) 1.10
Somatostatin receptor expression in the thyroid demonstrated with 111In-octreotide scintigraphy. Nuklearmedizin (1995) 1.09
MRI study of human brain exposed to weak direct current stimulation of the frontal cortex. Clin Neurophysiol (2004) 1.09
Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients. Eur J Endocrinol (2008) 1.06
Serum S100beta increases in marathon runners reflect extracranial release rather than glial damage. Neurology (2004) 1.06
Determination of hemisphere dominance for language: comparison of frontal and temporal fMRI activation with intracarotid amytal testing. Neuroradiology (2002) 1.05
Why do restless legs occur at rest?--pathophysiology of neuronal structures in RLS. Neurophysiology of RLS (part 2). Clin Neurophysiol (2004) 1.05
Prevalence, predictors and patterns of postoperative polyuria and hyponatraemia in the immediate course after transsphenoidal surgery for pituitary adenomas. Clin Endocrinol (Oxf) (1999) 1.05
Traumatic brain injury as a risk factor for Alzheimer disease. Comparison of two retrospective autopsy cohorts with evaluation of ApoE genotype. BMC Neurol (2001) 1.05
Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs. Electroencephalogr Clin Neurophysiol (1997) 1.05
Immunopathology of primary hypophysitis: implications for pathogenesis. Am J Surg Pathol (2005) 1.04
Xanthogranuloma of the sellar region: a clinicopathological entity different from adamantinomatous craniopharyngioma. Acta Neuropathol (1999) 1.04
Coil migration after endovascular coil occlusion of internal carotid artery pseudoaneurysms within the sphenoid sinus. Minim Invasive Neurosurg (2009) 1.04
Surgical treatment of craniopharyngiomas: endocrinological results. J Neurosurg (1999) 1.03
Effects of 10 Hz and 20 Hz transcranial alternating current stimulation (tACS) on motor functions and motor cortical excitability. Behav Brain Res (2012) 1.03
The effects of baclofen and cholinergic drugs on upbeat and downbeat nystagmus. J Neurol Neurosurg Psychiatry (1991) 1.03
Low-frequency repetitive transcranial magnetic stimulation improves intractable epilepsy. Lancet (1999) 1.02
Expression of tyrosine kinases FAK and Pyk2 in 331 human astrocytomas. Acta Neuropathol (2004) 1.02
Radiation therapy of optico-hypothalamic gliomas (OHG)--radiographic response, vision and late toxicity. Radiother Oncol (2000) 1.02
Surgical removal of pontomesencephalic cavernous hemangiomas. Neurosurgery (1990) 1.01
Prediction of postoperative outcome with special respect to removal of hemosiderin fringe: a study in patients with cavernous haemangiomas associated with symptomatic epilepsy. Seizure (2007) 1.01
Diffusion tensor imaging and white matter tractography in patients with brainstem lesions. Acta Neurochir (Wien) (2007) 1.01
Intraoperative magnetic resonance imaging combined with neuronavigation: a new concept. Neurosurgery (2001) 1.01
Octreotide exerts different effects in vivo and in vitro in Cushing's disease. Eur J Endocrinol (1994) 1.01
Multi-site voxel-based morphometry--not quite there yet. Neuroimage (2011) 1.01
Factors influencing the application accuracy of neuronavigation systems. Stereotact Funct Neurosurg (2000) 1.01
Changes in fiber integrity, diffusivity, and metabolism of the pyramidal tract adjacent to gliomas: a quantitative diffusion tensor fiber tracking and MR spectroscopic imaging study. AJNR Am J Neuroradiol (2007) 1.01
High-frequency repetitive transcranial magnetic stimulation delays rapid eye movement sleep. Neuroreport (1998) 1.00
Gene therapy for brain tumors. Brain Pathol (1995) 1.00
Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas. Am J Pathol (1995) 1.00
Knockdown of annexin 2 decreases migration of human glioma cells in vitro. Neuropathol Appl Neurobiol (2006) 1.00
Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma. Leukemia (2011) 0.99
Impact of pulse duration in single pulse TMS. Clin Neurophysiol (2010) 0.98
Primary central nervous system lymphomas--an update. J Cancer Res Clin Oncol (1992) 0.97
Magnetoencephalography in extratemporal epilepsy. J Clin Neurophysiol (2000) 0.97
Temporal lobe microdysgenesis in epilepsy versus control brains. J Neuropathol Exp Neurol (1999) 0.97
Identification of the visual motion area (area V5) in the human brain by dipole source analysis. Exp Brain Res (1993) 0.97
Effects of closed traumatic brain injury and genetic factors on the development of Alzheimer's disease. Eur J Neurol (2001) 0.96
Radiation therapy approach in gliomatosis cerebri--case reports and literature review. Acta Oncol (2000) 0.96
Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas -- a study on 721 patients. Acta Neurochir (Wien) (2004) 0.96